de Lima M - Search Results

1

Concurrent blinatumomab and donor lymphocyte infusions for treatment of relapsed pre-B-cell ALL after allogeneic hematopoietic cell transplant.

Ueda M, de Lima M, Caimi P, Tomlinson B, Little J, Creger R, Lazarus H, Cooper B. Ueda M, et al. Among authors: de lima m. Bone Marrow Transplant. 2016 Sep;51(9):1253-5. doi: 10.1038/bmt.2016.104. Epub 2016 Apr 18. Bone Marrow Transplant. 2016. PMID: 27088374 No abstract available.

2

Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma.

de Lima M, van Besien KW, Giralt SA, Khouri IF, Mehra R, Andersson BS, Przepiorka D, Gajewski JL, Korbling M, Champlin RE. de Lima M, et al. Bone Marrow Transplant. 1997 Jan;19(2):121-7. doi: 10.1038/sj.bmt.1700614. Bone Marrow Transplant. 1997. PMID: 9116608

3

Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect.

van Besien KW, de Lima M, Giralt SA, Moore DF Jr, Khouri IF, Rondón G, Mehra R, Andersson BS, Dyer C, Cleary K, Przepiorka D, Gajewski JL, Champlin RE. van Besien KW, et al. Among authors: de lima m. Bone Marrow Transplant. 1997 May;19(10):977-82. doi: 10.1038/sj.bmt.1700781. Bone Marrow Transplant. 1997. PMID: 9169641

4

High-dose melphalan and allogeneic peripheral blood stem cell transplantation for treatment of early relapse after allogeneic transplant.

de Lima M, van Besien K, Gajewski J, Khouri I, Andersson B, Korbling M, Champlin R, Giralt S. de Lima M, et al. Bone Marrow Transplant. 2000 Aug;26(3):333-8. doi: 10.1038/sj.bmt.1702521. Bone Marrow Transplant. 2000. PMID: 10967575 Clinical Trial.

5

Prophylactic donor lymphocyte infusions after moderately ablative chemotherapy and stem cell transplantation for hematological malignancies: high remission rate among poor prognosis patients at the expense of graft-versus-host disease.

de Lima M, Bonamino M, Vasconcelos Z, Colares M, Diamond H, Zalcberg I, Tavares R, Lerner D, Byington R, Bouzas L, da Matta J, Andrade C, Carvalho L, Pires V, Barone B, Maciel C, Tabak D. de Lima M, et al. Bone Marrow Transplant. 2001 Jan;27(1):73-8. doi: 10.1038/sj.bmt.1702726. Bone Marrow Transplant. 2001. PMID: 11244440

6

Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia.

Mittal P, Saliba RM, Giralt SA, Shahjahan M, Cohen AI, Karandish S, Onida F, Beran M, Champlin RE, de Lima M. Mittal P, et al. Among authors: de lima m. Bone Marrow Transplant. 2004 May;33(10):1005-9. doi: 10.1038/sj.bmt.1704472. Bone Marrow Transplant. 2004. PMID: 15048141

7

Donor leukocyte infusions in relapsed Hodgkin's lymphoma following allogeneic stem cell transplantation: CD3+ cell dose, GVHD and disease response.

Anderlini P, Acholonu SA, Okoroji GJ, Andersson BS, Couriel DR, De Lima MJ, Donato ML, Khouri IF, Giralt SA, Ueno NT, Champlin RE. Anderlini P, et al. Among authors: de lima mj. Bone Marrow Transplant. 2004 Sep;34(6):511-4. doi: 10.1038/sj.bmt.1704621. Bone Marrow Transplant. 2004. PMID: 15273710

8

Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant.

Eapen M, Giralt SA, Horowitz MM, Klein JP, Wagner JE, Zhang MJ, Tallman MS, Marks DI, Camitta BM, Champlin RE, Ringdén O, Bredeson CN, Martino R, Gale RP, Cairo MS, Litzow MR, deLima M. Eapen M, et al. Bone Marrow Transplant. 2004 Oct;34(8):721-7. doi: 10.1038/sj.bmt.1704645. Bone Marrow Transplant. 2004. PMID: 15322568

9

Reduced-intensity allogeneic stem cell transplantation in relapsed and refractory Hodgkin's disease: low transplant-related mortality and impact of intensity of conditioning regimen.

Anderlini P, Saliba R, Acholonu S, Okoroji GJ, Donato M, Giralt S, Andersson B, Ueno NT, Khouri I, De Lima M, Hosing C, Cohen A, Ippoliti C, Romaguera J, Rodriguez MA, Pro B, Fayad L, Goy A, Younes A, Champlin RE. Anderlini P, et al. Among authors: de lima m. Bone Marrow Transplant. 2005 May;35(10):943-51. doi: 10.1038/sj.bmt.1704942. Bone Marrow Transplant. 2005. PMID: 15806128

10

Disease burden may identify patients more likely to benefit from second allogeneic hematopoietic stem cell transplantation to treat relapsed acute myelogenous leukemia.

Hosing C, Saliba RM, Shahjahan M, Estey EH, Couriel D, Giralt S, Andersson B, Champlin RE, De Lima M. Hosing C, et al. Among authors: de lima m. Bone Marrow Transplant. 2005 Jul;36(2):157-62. doi: 10.1038/sj.bmt.1705011. Bone Marrow Transplant. 2005. PMID: 15937511

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,194 results

Search Page

Filters